TGFB1 and breast carcinoma: Studies have identified the possible role of TGFβ-1+29C/T polymorphism in the pathogenesis of osteoarthritis [18], breast cancer [19], urinary bladder cancer [20], development of cervical lesions [21], sarcopenia [22], and chronic periodontitis [23].